Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 1,843 | 2,223 | 3,800 | 2,437 | 4,214 |
| Operating Income | -1,843 | -2,223 | -3,800 | -2,437 | -4,214 |
| Interest Expense | 186 | 93 | 193 | 207 | 237 |
| Other Income | -94 | -64 | -569 | -23 | -77 |
| Pre-tax Income | -2,123 | -2,380 | -4,563 | -2,667 | -4,528 |
| Net Income Continuous | -2,123 | -2,380 | -4,563 | -2,667 | -4,528 |
| Minority Interests | 0 | -13 | -90 | -193 | -496 |
| Net Income | $-2,123 | $-2,367 | $-4,473 | $-2,473 | $-4,032 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.03 | -0.02 | -0.04 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.03 | -0.02 | -0.04 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.03 | -0.02 | -0.04 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.03 | -0.02 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.02 | -0.03 | N/A | -0.04 |
| EBITDA(a) | $-1,831 | $-1,537 | $-3,443 | $-2,114 | $-4,137 |